Market Cap 1.67B
Revenue (ttm) 1.91B
Net Income (ttm) 165.39M
EPS (ttm) N/A
PE Ratio 10.23
Forward PE 10.06
Profit Margin 8.64%
Debt to Equity Ratio 0.69
Volume 978,800
Avg Vol 787,150
Day's Range N/A - N/A
Shares Out 83.00M
Stochastic %K 55%
Beta 0.76
Analysts Sell
Price Target $21.50

Company Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-ba...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 954 384 0175
Address:
1301 Concord Terrace, Sunrise, United States
ZacksResearch
ZacksResearch Feb. 20 at 3:53 PM
$MD earnings miss — but is the headline hiding the real story? ⚠️ Q4 EPS missed estimates and revenues dipped, yet same-unit gains and a stronger 2026 EBITDA outlook point to improving underlying momentum. That’s a mixed setup investors shouldn’t ignore. Is this a turnaround brewing or more choppiness ahead? Get the full breakdown 👉 https://www.zacks.com/stock/news/2872924/pediatrix-medical-q4-earnings-miss-estimates-despite-declining-costs?cid=sm-stocktwits-2-2872924-teaser-34422&ADID=SYND_STOCKTWITS_TWEET_2_2872924_TEASER_34422
0 · Reply
ZacksResearch
ZacksResearch Feb. 20 at 2:53 PM
$MD misses EPS but beats revenue estimates — what's the full story? 🤔 Pediatrix Medical's Q4 2025 EPS of 50 cents missed the Zacks Consensus Estimate by 4.9%, while revenues of $493.8M beat projections by 0.5%. Despite higher variable practice incentive compensation and lower same-unit revenues, favorable collection activity, payor mix, improved patient acuity and lower operating expenses provided some support. Full breakdown here 👉 https://www.zacks.com/stock/news/2872924/pediatrix-medical-q4-earnings-miss-estimates-despite-declining-costs?cid=sm-stocktwits-2-2872924-body-34421&ADID=SYND_STOCKTWITS_TWEET_2_2872924_BODY_34421
0 · Reply
medguy
medguy Feb. 19 at 9:18 PM
Looking for bounce $BTDR $MD $HTZ
1 · Reply
Nova_Viper_9156
Nova_Viper_9156 Feb. 19 at 5:37 PM
$MD quiet tape but structure improving and if volume shows up watch for breakout pressure
0 · Reply
briefingcom
briefingcom Feb. 19 at 1:28 PM
$MD : Pediatrix Medical Group (-9.4%) misses by $0.04, beats on revs https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260219060512MD&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 19 at 11:58 AM
$MD Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.40 up 11.11% YoY • Reported revenue of $493.77M down -1.71% YoY • On a preliminary basis, Pediatrix anticipates its 2026 Adjusted EBITDA will be in a range of $280M to $300M, reflecting the company's outlook for the upcoming fiscal year.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 19 at 11:58 AM
$MD Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.40 up 11.11% YoY • Reported revenue of $493.77M down -1.71% YoY • On a preliminary basis, Pediatrix anticipates its 2026 Adjusted EBITDA will be in a range of $280M to $300M, as defined in the company's financial report.
0 · Reply
Estimize
Estimize Feb. 18 at 7:00 PM
$MD reports before the open tomorrow, Estimize Consensus +0.09 EPS and +5.43M Revs compared to WS http://www.estimize.com/md/fq4-2025?utm_c
0 · Reply
Estimize
Estimize Feb. 18 at 12:03 PM
Wall St is expecting 0.32 EPS for $MD Q1 [Reporting 04/30 BMO] http://www.estimize.com/intro/md?chart=historical&metric_name=eps&utm_conten
0 · Reply
Estimize
Estimize Feb. 9 at 7:21 PM
Wall St is expecting 0.32 EPS for $MD Q1 [Reporting 04/30 BMO] http://www.estimize.com/intro/md?chart=historical&metric_name=eps&utm_conten
0 · Reply
Latest News on MD
Pediatrix Medical Group Reports Fourth Quarter Results

Feb 19, 2026, 6:00 AM EST - 7 days ago

Pediatrix Medical Group Reports Fourth Quarter Results


Pediatrix Medical Group Reports Third Quarter Results

Nov 3, 2025, 6:00 AM EST - 4 months ago

Pediatrix Medical Group Reports Third Quarter Results


Pediatrix Medical Group Reports Second Quarter Results

Aug 5, 2025, 6:00 AM EDT - 7 months ago

Pediatrix Medical Group Reports Second Quarter Results


Pediatrix Board Appoints Kurt D. Newman, M.D.

Jul 1, 2025, 4:05 PM EDT - 8 months ago

Pediatrix Board Appoints Kurt D. Newman, M.D.


Pediatrix Medical Group Reports First Quarter Results

May 6, 2025, 6:00 AM EDT - 10 months ago

Pediatrix Medical Group Reports First Quarter Results


Pediatrix Board Appoints Sylvia Young as Independent Director

May 4, 2023, 4:05 PM EDT - 3 years ago

Pediatrix Board Appoints Sylvia Young as Independent Director


James D. Swift, M.D., Elected to Pediatrix Board of Directors

Mar 8, 2023, 5:36 PM EST - 3 years ago

James D. Swift, M.D., Elected to Pediatrix Board of Directors


Pediatrix Announces Leadership Transitions

Dec 15, 2022, 4:41 PM EST - 3 years ago

Pediatrix Announces Leadership Transitions


Pediatrix: These 5 Graphs Suggest It's A Buy

Sep 29, 2022, 12:52 PM EDT - 3 years ago

Pediatrix: These 5 Graphs Suggest It's A Buy


ZacksResearch
ZacksResearch Feb. 20 at 3:53 PM
$MD earnings miss — but is the headline hiding the real story? ⚠️ Q4 EPS missed estimates and revenues dipped, yet same-unit gains and a stronger 2026 EBITDA outlook point to improving underlying momentum. That’s a mixed setup investors shouldn’t ignore. Is this a turnaround brewing or more choppiness ahead? Get the full breakdown 👉 https://www.zacks.com/stock/news/2872924/pediatrix-medical-q4-earnings-miss-estimates-despite-declining-costs?cid=sm-stocktwits-2-2872924-teaser-34422&ADID=SYND_STOCKTWITS_TWEET_2_2872924_TEASER_34422
0 · Reply
ZacksResearch
ZacksResearch Feb. 20 at 2:53 PM
$MD misses EPS but beats revenue estimates — what's the full story? 🤔 Pediatrix Medical's Q4 2025 EPS of 50 cents missed the Zacks Consensus Estimate by 4.9%, while revenues of $493.8M beat projections by 0.5%. Despite higher variable practice incentive compensation and lower same-unit revenues, favorable collection activity, payor mix, improved patient acuity and lower operating expenses provided some support. Full breakdown here 👉 https://www.zacks.com/stock/news/2872924/pediatrix-medical-q4-earnings-miss-estimates-despite-declining-costs?cid=sm-stocktwits-2-2872924-body-34421&ADID=SYND_STOCKTWITS_TWEET_2_2872924_BODY_34421
0 · Reply
medguy
medguy Feb. 19 at 9:18 PM
Looking for bounce $BTDR $MD $HTZ
1 · Reply
Nova_Viper_9156
Nova_Viper_9156 Feb. 19 at 5:37 PM
$MD quiet tape but structure improving and if volume shows up watch for breakout pressure
0 · Reply
briefingcom
briefingcom Feb. 19 at 1:28 PM
$MD : Pediatrix Medical Group (-9.4%) misses by $0.04, beats on revs https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260219060512MD&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 19 at 11:58 AM
$MD Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.40 up 11.11% YoY • Reported revenue of $493.77M down -1.71% YoY • On a preliminary basis, Pediatrix anticipates its 2026 Adjusted EBITDA will be in a range of $280M to $300M, reflecting the company's outlook for the upcoming fiscal year.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 19 at 11:58 AM
$MD Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.40 up 11.11% YoY • Reported revenue of $493.77M down -1.71% YoY • On a preliminary basis, Pediatrix anticipates its 2026 Adjusted EBITDA will be in a range of $280M to $300M, as defined in the company's financial report.
0 · Reply
Estimize
Estimize Feb. 18 at 7:00 PM
$MD reports before the open tomorrow, Estimize Consensus +0.09 EPS and +5.43M Revs compared to WS http://www.estimize.com/md/fq4-2025?utm_c
0 · Reply
Estimize
Estimize Feb. 18 at 12:03 PM
Wall St is expecting 0.32 EPS for $MD Q1 [Reporting 04/30 BMO] http://www.estimize.com/intro/md?chart=historical&metric_name=eps&utm_conten
0 · Reply
Estimize
Estimize Feb. 9 at 7:21 PM
Wall St is expecting 0.32 EPS for $MD Q1 [Reporting 04/30 BMO] http://www.estimize.com/intro/md?chart=historical&metric_name=eps&utm_conten
0 · Reply
ClusterIQ
ClusterIQ Feb. 4 at 1:42 PM
$MD is a pediatric healthcare services provider; its model is resilient due to essential service nature, but staffing shortages and reimbursement rates pressure margins.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 24 at 12:21 PM
$MD RSI: 52.29, MACD: -0.0071 Vol: 0.36, MA20: 21.98, MA50: 22.43 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 7 at 3:32 PM
$MD Current Stock Price: $22.18 Contracts to trade: $20 MD Jan 16 2026 Call Entry: $0.75 Exit: $1.21 ROI: 61% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 4:40 PM
$MD is quietly crushing its peers — and the market is finally noticing. Pediatrix Medical is positioned for growth on stronger collections, an improving payer mix, and acquisitions, with shares up 55.2% in six months versus the industry’s 6.7% gain. 📊🚀 See why MD could be a smart portfolio addition here 👉 https://www.zacks.com/stock/news/2811350/heres-why-pediatrix-medical-can-be-a-smart-addition-to-your-portfolio?cid=sm-stocktwits-2-2811350-teaser-27173&ADID=SYND_STOCKTWITS_TWEET_2_2811350_TEASER_27173
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 3:40 PM
$MD up 55.2% in 6 months! What's driving this surge? 🚀 🔹 Zacks Rank #1 (Strong Buy) with a forward P/E of 10.35X vs. industry’s 17.93X 🔹 2025 earnings estimate up 37.1% from 2024, with 5 upward revisions 🔹 Strategic M&A activities fueling growth See what makes this a standout in the medical space 👉 https://www.zacks.com/stock/news/2811350/heres-why-pediatrix-medical-can-be-a-smart-addition-to-your-portfolio?cid=sm-stocktwits-2-2811350-body-27152&ADID=SYND_STOCKTWITS_TWEET_2_2811350_BODY_27152
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 12 at 9:35 PM
$MD Current Stock Price: $22.50 Contracts to trade: $20 MD Dec 19 2025 Call Entry: $0.90 Exit: $1.60 ROI: 78% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
kshonstocks
kshonstocks Nov. 14 at 8:16 PM
$MD v good ibd https://research.investors.com/stock-quotes/nyse-pediatrix-medical-md.htm
0 · Reply
TheUnmaker
TheUnmaker Nov. 11 at 4:10 PM
$BB Why would I ever sell? Just buy more! $MD $NVDA $MSFT $AMZN
1 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 5:04 PM
Truist Securities updates rating for Pediatrix Medical Group ( $MD ) to Hold, target set at 17 → 24.
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 6 at 10:07 PM
$MD Share Price: $21.83 Contract Selected: May 15, 2026 $20 Calls Buy Zone: $2.25 – $2.78 Target Zone: $4.27 – $5.22 Potential Upside: 79% ROI Time to Expiration: 189 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 5:49 PM
$MD beat Q3 earnings even with softer revenues 💪 Lower expenses and improved patient acuity boosted profitability, helping results top estimates. See the full Q3 snapshot here 👉 https://www.zacks.com/stock/news/2787093/pediatrix-medical-q3-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2787093-teaser-19889&ADID=SYND_STOCKTWITS_TWEET_2_2787093_TEASER_19889
0 · Reply
ZacksResearch
ZacksResearch Nov. 6 at 4:49 PM
$MD beats Q3 estimates with a 52.3% EPS surge — what's behind the quarterly results? 🚀 📈 Higher collection activity and improved patient acuity 🛠️ Operating expenses down 11% year over year 💸 Share repurchase program update Full details here 👉 https://www.zacks.com/stock/news/2787093/pediatrix-medical-q3-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2787093-body-19863&ADID=SYND_STOCKTWITS_TWEET_2_2787093_BODY_19863
0 · Reply